Amwell (AMWL) reported Q2 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $64.5 million versus the consensus estimate of $64.13 million.
GUIDANCE:
Amwell sees FY2022 revenue of $275-285 million, versus the consensus of $276.8 million.